Insights - It appears that PropThink wasn’t the only firm to notice that ViroPharma’s (VPHM) third quarter results signaled the start of some very promising trends. On … Continue Reading
Read NowInsights - Salix Pharmaceuticals (SLXP) jumped nearly 18% last week on news that it agreed to acquire Santarus, Inc. (SNTS). The combined companies will be the leading … Continue Reading
Read NowInsights - The bad news keeps coming at Coronado Biosciences (CNDO), although based on recent history, the news wasn’t a major surprise. In mid-October, CNDO announced that … Continue Reading
Read NowInsights - NPS Pharmaceuticals (NPSP) shares traded down 14% on Wednesday, despite reporting strong third quarter results and raising guidance for 2013. The weakness appears to stem … Continue Reading
Read NowInsights - ImmunoGen’s (IMGN) gave up most of this year’s gains when the company announced that it was stopping a phase 2 clinical trial of IMGN901 in … Continue Reading
Read NowInsights - Moving from target to hunter, Endo Health (ENDP) announced plans to purchase Paladin Labs (PLB.TO), a Canadian specialty pharmaceutical manufacturer, for $1.5 billion. Both companies … Continue Reading
Read NowInsights - In an important phase 3 trial, Merck’s (MRK) new investigational 9-valent Human Papilloma virus (HPV) vaccine, known as V503, compared favorably to the company’s current vaccine, … Continue Reading
Read Now
